Ubs Oconnor LLC Immunic, Inc. Transaction History

Ubs Oconnor LLC

$1.72 Billion
Q2 2024

A detailed history of Ubs Oconnor LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 117,685 shares of IMUX stock, worth $138,868. This represents 0.01% of its overall portfolio holdings.

Number of Shares

117,685

Holding current value

$138,868

% of portfolio

0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.98 - $1.44 $49,000 - $72,000	-50,000 Reduced 29.82%	117,685 $130,000
Q1 2024 May 15, 2024	SELL	$1.14 - $1.53 $493,105 - $661,799	-432,549 Reduced 72.06%	167,685 $221,000
Q4 2023 Feb 14, 2024	SELL	$0.97 - $1.6 $156,609 - $258,324	-161,453 Reduced 21.2%	600,234 $900,000
Q3 2023 Nov 14, 2023	SELL	$1.35 - $2.87 $40,500 - $86,100	-30,000 Reduced 3.79%	761,687 $1.12 Million
Q2 2023 Aug 14, 2023	BUY	$1.33 - $2.51 $1.05 Million - $1.99 Million	791,687 New	791,687 $1.99 Billion
Q1 2023 May 15, 2023	BUY	$1.35 - $2.87 $183,929 - $391,020	136,244 Added 24.78%	686,132 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$1.13 - $10.8 $397,646 - $3.8 Million	351,900 Added 177.74%	549,888 $0
Q3 2022 Nov 14, 2022	SELL	$3.0 - $5.49 $103,809 - $189,970	-34,603 Reduced 14.88%	197,988 $626 Million
Q2 2022 Aug 12, 2022	BUY	$3.13 - $12.25 $415,009 - $1.62 Million	132,591 Added 132.59%	232,591 $807,000
Q1 2022 May 16, 2022	BUY	$9.54 - $14.26 $953,999 - $1.43 Million	100,000 New	100,000 $1.13 Million

Others Institutions Holding IMUX

# of Institutions

Shares Held

56M

Call Options Held

4.7K

Put Options Held

311K

Bvf Inc San Francisco, CA

8.9M
Shares

$10.5 Million
0.3% of portfolio
Avidity Partners Management LP Dallas, TX

8.9M
Shares

$10.5 Million
0.49% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

7.29M
Shares

$8.61 Million
0.82% of portfolio
Janus Henderson Group PLC London, X0

7.07M
Shares

$8.35 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

5.59M
Shares

$6.6 Million
0.01% of portfolio

View Full List

About IMMUNIC, INC.

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

More about IMUX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account